Dr So-Ryoung Lee (Seoul National University Hospital, Seoul, KR) joins us on-site at EHRA Congress 2025 to discuss key considerations that must be made in order to identify patients who will benefit from conduction system pacing.
Interview Questions:
1. How do current guidelines address patient selection for conduction system pacing for cardiac resynchronization therapy in heart failure patients, and what are the gaps in these recommendations?
2. What are the key clinical and ECG indicators that suggest a patient might not respond to conduction system pacing?
3. What comorbidities are associated with reduced benefit from conduction system pacing?
4. What procedural challenges might lead you to determine a patient is not suitable for conduction system pacing?
5. How has your approach to patient selection evolved with increased clinical experience and emerging data?
6. What changes would you like to see in future guidelines to better clarify which patients should not undergo conduction system pacing?
Recorded on-site at EHRA in Vienna, 2025.
Support: This is an independent interview produced by Arrhythmia Academy.
Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook: https://www.facebook.com/RadcliffeCardiology
Follow us on X: https://x.com/radcliffeCARDIO
Interview Questions:
1. How do current guidelines address patient selection for conduction system pacing for cardiac resynchronization therapy in heart failure patients, and what are the gaps in these recommendations?
2. What are the key clinical and ECG indicators that suggest a patient might not respond to conduction system pacing?
3. What comorbidities are associated with reduced benefit from conduction system pacing?
4. What procedural challenges might lead you to determine a patient is not suitable for conduction system pacing?
5. How has your approach to patient selection evolved with increased clinical experience and emerging data?
6. What changes would you like to see in future guidelines to better clarify which patients should not undergo conduction system pacing?
Recorded on-site at EHRA in Vienna, 2025.
Support: This is an independent interview produced by Arrhythmia Academy.
Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook: https://www.facebook.com/RadcliffeCardiology
Follow us on X: https://x.com/radcliffeCARDIO
- Category
- Cardiology

Be the first to comment